Altered somatic hypermutation patterns in COVID-19 patients classifies disease severity

Modi Safra, Zvi Tamari, Pazit Polak, Shachaf Shiber, Moshe Matan, Hani Karameh, Yigal Helviz, Adva Levy-Barda, Vered Yahalom, Avi Peretz, Eli Ben-Chetrit, Baruch Brenner, Tamir Tuller, Meital Gal-Tanamy, Gur Yaari*

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

8 Scopus citations

Abstract

Introduction: The success of the human body in fighting SARS-CoV2 infection relies on lymphocytes and their antigen receptors. Identifying and characterizing clinically relevant receptors is of utmost importance. Methods: We report here the application of a machine learning approach, utilizing B cell receptor repertoire sequencing data from severely and mildly infected individuals with SARS-CoV2 compared with uninfected controls. Results: In contrast to previous studies, our approach successfully stratifies non-infected from infected individuals, as well as disease level of severity. The features that drive this classification are based on somatic hypermutation patterns, and point to alterations in the somatic hypermutation process in COVID-19 patients. Discussion: These features may be used to build and adapt therapeutic strategies to COVID-19, in particular to quantitatively assess potential diagnostic and therapeutic antibodies. These results constitute a proof of concept for future epidemiological challenges.

Original languageEnglish
Article number1031914
JournalFrontiers in Immunology
Volume14
DOIs
StatePublished - 2023

Funding

FundersFunder number
Bar Ilan Data Science Institute and Israeli Council for Higher Education
Israeli Ministry of Science3-16909
Horizon 2020 Framework Programme825821
United States-Israel Binational Science Foundation2017253
Israel Science Foundation3768/19

    Keywords

    • AIRR-seq
    • B cell
    • BCR
    • COVID-19
    • machine learning
    • somatic hypermutation

    Fingerprint

    Dive into the research topics of 'Altered somatic hypermutation patterns in COVID-19 patients classifies disease severity'. Together they form a unique fingerprint.

    Cite this